These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4475170)

  • 1. [Treatment of chronic glomerulonephritis with steroids and immunosuppressive agents].
    Ono J
    Nihon Rinsho; 1974 Oct; 32(10):3107-13. PubMed ID: 4475170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
    Bonomini V; Mioli V; Albertazzi A; Vangelista A
    Minerva Nefrol; 1969; 16(2):103-19. PubMed ID: 5398499
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H
    Munch Med Wochenschr; 1969 Aug; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract]   [Full Text] [Related]  

  • 5. [Steroid therapy of the nephrotic form of chronic glomerulonephritis].
    Pyrig LA
    Vrach Delo; 1973 Jan; 1():82-4. PubMed ID: 4722297
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of glomerulonephritis].
    Attman PO; Bengtsson U
    Lakartidningen; 1975 Apr; 72(16):1663-8. PubMed ID: 1128073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
    Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C; Banfi G; Imbasciati E; Tarantino A
    Contrib Nephrol; 1982; (34):33-54. PubMed ID: 6293765
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of rapidly progressive glomerulonephritis with immunosuppressive agents.
    Savin M; Djukanović Lj; Sindjić M; Pavlović S; Dimitrijević J; Nestić V
    Srp Arh Celok Lek; 1997; 125(7-8):207-13. PubMed ID: 9304233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunosuppressive therapy in adult glomerulonephritis.
    Ojeda W; Cangiano JL; Campos JA; González RR; Vázquez J; Muxó OR
    Bol Asoc Med P R; 1976 Jun; 68(6):137-40. PubMed ID: 779806
    [No Abstract]   [Full Text] [Related]  

  • 14. [32 cases of nephrosis in children. Improvement of the prognosis by immunosuppressive drugs].
    Mongeau JG; Robillard J
    Union Med Can; 1968 Nov; 97(11):1578-85. PubMed ID: 5746556
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic problems of glomerulonephritis].
    Dutz H; Philipp H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):554-60. PubMed ID: 5570284
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive therapy (azathioprine and chlorambucil) in some nephrosic syndromes and in chronic active glomerulonephritis].
    Campanacci L; Castellani A; Gambari PF; Fagiolo U; Romagnoli GF
    Minerva Nefrol; 1969; 16(2):130-56. PubMed ID: 4921663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of the effectiveness of treatment of chronic diffuse glomerulonephritis].
    Riabov SI; Blozshteĭn IG; Diskina DB; Zhdanova LD; Minkin RB
    Ter Arkh; 1976; 48(7):100-7. PubMed ID: 996735
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic glomerulopathy].
    Orlowski T; Gradowska L; Lao M; Rancewicz Z; Rowinska D
    Z Gesamte Inn Med; 1972 Nov; 27(22):980-3. PubMed ID: 4649659
    [No Abstract]   [Full Text] [Related]  

  • 19. [Steroid therapy in nephrosic syndrome. Evaluation of the results in connection with initial nephro-bioptic changes and glomerular permeability to proteins].
    Maiorca R; Scarpioni L; Cambi V; Carrara GC; Dall'Aglio P
    Minerva Nefrol; 1969; 16(2):120-9. PubMed ID: 5398500
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stage-by-stage treatment of patients with chronic glomerulonephritis].
    Androsova SO; Nevraeva OG
    Urol Nefrol (Mosk); 1977; (2):18-23. PubMed ID: 855043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.